SGP vs SIBN: stock comparison and AI forecast
Spyglass Pharma, Inc. (SGP) and Si-Bone, Inc. (SIBN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
SGP Spyglass Pharma, Inc.
- Price
- $34.08 +34.2% · 6M
- Market Cap
- $1.14B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SIBN Si-Bone, Inc.
- Market Cap
- $1.09B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- SGP and SIBN have similar market capitalizations ($1.14B and $1.09B).
- SIBN carries 0.39 times debt per unit of equity, against 0.05 times for SGP.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | SGP | SIBN |
|---|---|---|
| Market Cap | $1.14B | $1.09B |
| P/B Ratio | 4.91x | 5.89x |
| EPS | – | $-0.41 |
| Book Value/Share | $6.95 | $4.12 |
| Revenue/Share | – | $4.92 |
| FCF/Share | – | $-0.09 |
Profitability & Margins
| Metric | SGP | SIBN |
|---|---|---|
| ROE | – | -7.4% |
| ROA | – | -5.3% |
| ROIC | – | -7.4% |
| Gross Margin | – | 79.4% |
| Operating Margin | – | -7.6% |
| Net Margin | – | -6.2% |
| EBT Margin | – | -6.0% |
| Tax Rate | – | 0.0% |
Financial Health
| Metric | SGP | SIBN |
|---|---|---|
| Current Ratio | 25.06x | 7.58x |
| Quick Ratio | – | 6.15x |
| D/E Ratio | 0.05x | 0.39x |
| Financial Leverage | 1.05x | 1.39x |
| Interest Coverage | – | -1.0x |
| Working Capital | $227M | $195M |
Cash Flow
| Metric | SGP | SIBN |
|---|---|---|
| Operating Cash Flow | – | $6M |
| Free Cash Flow | – | -$4M |
| Capital Spending | – | -$10M |
| FCF/Sales | – | -1.9% |
| CapEx/Sales | – | 4.7% |
Operational Efficiency
| Metric | SGP | SIBN |
|---|---|---|
| Asset Turnover | – | 0.86x |
| Receivables Turnover | – | 7.0x |
| Inventory Turnover | – | 1.1x |
| Fixed Assets Turnover | – | 8.7x |
| Days Sales Outstanding | – | 52 days |
| Days Inventory | – | 340 days |
| Payables Period | – | 84 days |
| Cash Conversion Cycle | – | 308 days |
Income Statement
| Metric | SGP | SIBN |
|---|---|---|
| Total Revenue | – | $221M |
| Operating Income | – | -$17M |
| Net Income | – | -$14M |
| R&D Expense | – | $18M |
| SG&A Expense | – | $219M |
| Cost of Goods Sold | – | $45M |
Dividend & Shareholder Information
| Metric | SGP | SIBN |
|---|---|---|
| Shares Outstanding | 33M | 45M |
SGP vs SIBN: stock comparison and AI forecast
Which is bigger, SGP or SIBN?
SGP and SIBN have similar market capitalizations ($1.14B and $1.09B).
Which one does Intratio's AI model rank higher, SGP or SIBN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.